Abeona Therapeutics
ABEO
ABEO
70 hedge funds and large institutions have $98.6M invested in Abeona Therapeutics in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.1% more ownership
Funds ownership: 1.43% → 1.53% (+0.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
Holders
70
Holding in Top 10
1
Calls
$4M
Puts
$95K
Top Buyers
| 1 | +$6.25M | |
| 2 | +$1.9M | |
| 3 | +$1.6M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$1.38M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.32M |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$1.38M | |
| 3 | -$1.28M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$983K |
| 5 |
NC
Nexthera Capital
New York
|
-$897K |